22 Jun 2021 --- 108Labs is building a “Cellufacturing” facility for cell-based human milk, targeting a ton of milk production per day in the first stage. The US-based company expects to spend a “few million” on the pilot factory build-out over the next couple of years. CEO Shayne Giuliano tells NutritionInsight that Colostrupedics whole-human infant formula could hit shelves in three to four years, but the cost of production and scalability remain primary obstacles. Therefore, the factory design will allow for continuous scalability with no ceiling.
